• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔静脉分流术可恢复难治性肝腹水患者对心房利钠因子的反应性。

Peritoneovenous shunting restores atrial natriuretic factor responsiveness in refractory hepatic ascites.

作者信息

Tobe S W, Morali G A, Greig P D, Logan A, Blendis L M

机构信息

Department of Medicine, University of Toronto, Canada.

出版信息

Gastroenterology. 1993 Jul;105(1):202-7. doi: 10.1016/0016-5085(93)90027-a.

DOI:10.1016/0016-5085(93)90027-a
PMID:8514035
Abstract

BACKGROUND

Sodium retention in cirrhosis has been attributed to an imbalance between vasoconstrictive, antinatriuretic forces such as the renin aldosterone angiotensin system and the sympathetic nervous system, and vasodilatory, natriuretic agents such as atrial natriuretic factor (ANF). Patients with diuretic resistant refractory ascites may require peritoneovenous shunting (PVS) to control ascites.

METHODS

To study the factors responsible for the improvement in sodium homeostasis post-PVS, we compared the response to ANF infusion before and 1 month after PVS in 6 patients with massive ascites.

RESULTS

Before PVS, sodium excretion at baseline and in response to ANF infusion was blunted but became more normal post-PVS. ANF infusion post-PVS induced a significant increase in the glomerular filtration rate and filtration fraction and also in distal delivery of sodium. ANF's distal effect of increasing the fractional excretion of distally delivered sodium was present pre-PVS and was not significantly increased post-PVS. Changes in sodium handling were accompanied by a significant decrease in antinatriuretic forces (baseline aldosterone, 2079 +/- 507 vs. 647 +/- 17 nmol/L; P < 0.04) post-PVS.

CONCLUSIONS

The improvement in sodium homeostasis and response to ANF infusion post-PVS appears to be associated with the decrease in antinatriuretic forces with the loss of massive refractory ascites. Thus, PVS restores the balance toward ANF responsiveness.

摘要

背景

肝硬化患者的钠潴留被认为是由于血管收缩性、抗利尿因子如肾素-醛固酮-血管紧张素系统和交感神经系统与血管舒张性、利钠因子如心房利钠因子(ANF)之间的失衡所致。利尿剂抵抗的难治性腹水患者可能需要进行腹腔静脉分流术(PVS)来控制腹水。

方法

为了研究PVS后钠稳态改善的相关因素,我们比较了6例大量腹水患者在PVS前及PVS后1个月对ANF输注的反应。

结果

PVS前,基线时及对ANF输注的钠排泄受到抑制,但PVS后变得较为正常。PVS后输注ANF可使肾小球滤过率和滤过分数显著增加,同时钠向远端的输送也增加。PVS前就存在ANF增加远端输送钠的分数排泄的远端效应,PVS后未显著增加。钠处理的变化伴随着PVS后抗利尿因子的显著降低(基线醛固酮,2079±507对647±17 nmol/L;P<0.04)。

结论

PVS后钠稳态的改善及对ANF输注的反应似乎与抗利尿因子的降低以及大量难治性腹水的消失有关。因此,PVS恢复了对ANF反应性的平衡。

相似文献

1
Peritoneovenous shunting restores atrial natriuretic factor responsiveness in refractory hepatic ascites.腹腔静脉分流术可恢复难治性肝腹水患者对心房利钠因子的反应性。
Gastroenterology. 1993 Jul;105(1):202-7. doi: 10.1016/0016-5085(93)90027-a.
2
Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
Am J Med. 1991 Oct;91(4):383-92. doi: 10.1016/0002-9343(91)90156-r.
3
Angiotensin II modulates atrial natriuretic factor-induced natriuresis in cirrhosis with ascites.
Am J Kidney Dis. 1993 May;21(5):472-9. doi: 10.1016/s0272-6386(12)80392-1.
4
Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.肝硬化难治性腹水:容量扩张和血浆心钠素水平升高的作用
Hepatology. 1993 Sep;18(3):519-28.
5
Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation.肝硬化腹水患者的血浆心钠素。腹腔静脉分流植入术的影响。
Gastroenterology. 1988 Sep;95(3):764-70. doi: 10.1016/s0016-5085(88)80026-x.
6
Acute effects of peritoneovenous shunting on plasma atrial natriuretic peptide in cirrhotic patients with massive refractory ascites.腹腔静脉分流术对伴有大量难治性腹水的肝硬化患者血浆心钠素的急性影响。
Am J Med. 1988 Jan;84(1):112-9. doi: 10.1016/0002-9343(88)90017-4.
7
The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.利用腹腔静脉分流术阐明肝硬化腹水的发病机制。
Isr J Med Sci. 1986 Feb;22(2):78-80.
8
Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.肝硬化伴张力性腹水患者的心房利钠因子。大量腹腔穿刺放液的影响。
Gastroenterology. 1990 Apr;98(4):1063-70. doi: 10.1016/0016-5085(90)90034-x.
9
Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol.顽固性腹水:甘露醇对心房利钠因子无反应性的调节作用
Hepatology. 1992 Jul;16(1):42-8. doi: 10.1002/hep.1840160109.
10
[Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
Z Kardiol. 1988;77 Suppl 2:99-103.

引用本文的文献

1
Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis.利钠肽治疗肝硬化腹水的疗效与安全性:一项系统评价和荟萃分析。
World J Hepatol. 2022 Apr 27;14(4):827-845. doi: 10.4254/wjh.v14.i4.827.